Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Triple whammy improves acne outcomes

By Alisdair Stirling

Using a triple combination therapy for patients with moderate to severe acne vulgaris shows significantly improved outcomes, a study suggests.

A total of 378 patients were randomly assigned to receive 300mg lymecycline orally once daily given in combination with either topical adapalene 0.1% and benzoyl peroxide 2.5% or a vehicle gel, for 12 weeks.

Both groups showed a significant reduction in inflammatory and noninflammatory lesions at week 12, although patients taking the combination therapy displayed a faster onset of action from week two for non-inflammatory lesions and week four for inflammatory lesions.

Patients in the combination group showed a significantly greater reduction in total lesion count at 12 weeks - 74.1% - than those in the vehicle group - 56.8%.

The success rate - determined by clear or almost clear skin - was significantly higher in the combination group, at 47.6% than vehicle group, at 33.7%.

Lead researcher Professor Brigitte Dréno, head of the department of dermatology at the university hospital Nantes concluded: 'These results demonstrated the clinical benefit of combining adapalene and benzoyl peroxide with lymecycline in the treatment of acne vulgaris.'

Br J Dermatol 2011 published online 29 April

Triple whammy improves acne outcomes

Pulse seminar: Dermatology Update 2012

Rate this article  (4 average user rating)

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say